| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ANI PHARMACEUTICALS INC | Director | Common Stock | 25,157 | $2,041,490 | $81.15 | 05 Dec 2025 | Direct |
| Cardiff Oncology, Inc. | Director | Stock Options | 128,201 | $333,323 | $2.60 | 27 Jun 2024 | Direct |
| Cardiff Oncology, Inc. | Director | Common Stock | 20,000 | $68,448 | $3.42 | 12 Dec 2024 | Direct |
| Cardiff Oncology, Inc. | Director | Stock Options | 168,766 | 26 Jun 2025 | Direct | ||
| ZOGENIX, INC. | Director | Common Stock | 0 | $26.04 | 07 Mar 2022 | Direct | |
| ZOGENIX, INC. | Director | Stock Option (Right to Buy) | 0 | $26.09 | 07 Mar 2022 | Direct |